The xMAP® BioPharma eBook: Learn more and get ahead
We have bundled our most recent application notes exploring how our xMAP® Technology can be used in Drug Discovery Research and Development, taking tips from xMAP® experts across a variety of research areas.
This inaugural edition of the xMAP® BioPharma eBook highlights three exciting examples of commonly used applications in drug discovery and development.
Read reports from leading scientific teams working to:
Develop anti-cancer vaccines
Evaluate immunogenicity in an anti-inflammatory biologic using a streamlined multiplex approach
Characterize interactions among G protein-coupled receptors and receptor activity-modifying proteins
Dive into the xMAP® BioPharma eBook now for an inside look at the latest multiplexing strategies.
xMAP® Connect: Join us for the latest insights and updates
Join us every Wednesday for eight weeks of expert-led webinars starting October 1, every Wednesday at 11:00 a.m. ET/8:00 a.m. PT. Discover the latest advancements in xMAP Technology, connect with our Partners at their virtual booths, and get your questions answered during the live Q&A at the end of each session. Whether you're developing your own assay or just exploring the technology, these webinars are packed with insights you won't want to miss.
Genetic Analysis—discover the first diagnostic biomarker for antibiotic-induced microbiome imbalances
Genetic Analysis AS launches a novel Research Use Only test, the GA-map® MHI GutHealth, providing clinically actionable insights into antibiotic-induced gut microbiome imbalances. The assay combines xMAP Technology with the validated Microbiome Health Index™ (MHI) biomarker from Ferring Pharmaceuticals and is demonstrated in recurrent Clostridioides difficile (rCDI) infected patients.
The test provides an MHI score on a scale from 1 to 6, where a low MHI indicates antibiotic-induced disruptions of the microbiome. It offers rapid baseline microbiome imbalance assessment and enables monitoring of microbiome restoration treatment in rCDI and other infectious diseases, Graft-versus-Host Disease, and immunocompromised patients.
Streamline your AAV serotyping with innovative new assays
The MILLIPLEX® AAV Serotyping Magnetic Bead Panel is a groundbreaking assay that enables the simultaneous detection of antibodies for six AAV serotypes: AAV1, AAV2, AAV5, AAV6, AAV8, and AAV9. This comprehensive solution includes all necessary reagents and features a user-friendly protocol, offering outstanding precision and specificity with minimal cross-reactivity. It serves as a vital tool for preclinical evaluations in gene therapy and vaccine development research.
Fetch the latest in animal health research with our growing selection of MILLIPLEX® assays
Explore the comprehensive portfolio of MILLIPLEX® multiplex assays designed specifically for veterinary medicine and animal health research. Whether you’re working with companion animals or livestock, these panels deliver precise, simultaneous measurement of cytokines and inflammatory markers across a wide range of species. Gain the data you need to drive discovery and enhance animal care, all with the efficiency and accuracy you expect from MILLIPLEX® kits.
Whether you’re new to multiplexing or looking to enhance your existing skills, don’t miss your chance to access a range of self-paced resources to help elevate your expertise.
Multiplex Academy is your go-to learning platform for Luminex xMAP Technology and Invitrogen™ Luminex assays. It offers a range of interactive modules, short videos, expert webinars, and technical documents. Learn the basics of multiplexing at your own pace on your own time, while preparing for multiplex protein and gene analysis on your Luminex instrument.
New Invitrogen ProcartaPlex multiplex immunoassays for CNS conditions
A variety of conditions affecting the central nervous system (CNS), such as brain trauma, stroke, multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease, can trigger neuroinflammation and disrupt the blood-brain barrier. This disruption may lead to elevated concentrations of brain-specific molecules in circulation.
The new Invitrogen™ ProcartaPlex™ multiplex immunoassays for CNS conditions enable the quantification of up to 21 protein targets associated with neurodegeneration, brain injury, and neuroinflammation. Explore our comprehensive target list, featuring unique markers like Neurofilament-Light (NF-L), and gain deeper insights into CNS pathologies.
Get the most out of your multiplexing: updated Luminex Assay Guide
Check out the updated R&D Systems Luminex Assays User Guide. This guide is designed to help optimize assay performance, troubleshoot issues, and fine-tune workflows. Whether you're running custom panels or predefined ones, this updated guide offers practical tips to support consistent, high-quality data.
Multiplex analysis of inflammatory markers using Bio-Plex Pro™ Human Th17 Cytokine Assays
Th17 cells are an important subclass of T-helper lymphocytes that produce IL-17 and other cytokines that play a key role in inflammation-associated conditions such as antimicrobial immunity, cancer, transplant rejection, and autoimmune diseases including rheumatoid arthritis, multiple sclerosis, lupus and psoriasis. This application article summarizes the validation studies performed on the Bio-Plex Pro™ Human Th17 Cytokine Assays that cover all 16 markers in singleplex and multiplex formats.
These products are for Research Use Only. Not for use in diagnostic procedures. Please contact Luminex at support@luminexcorp.com to obtain the appropriate product information for your country of residence.
-1.png?upscale=true&width=1200&upscale=true&name=Untitled%20design%20(20)-1.png)
